- ABOUT IMC
- IoT LIBRARY
- RFP PROGRAMME
Bloom deploys Presagen AI to aid pregnancy
- October 12, 2022
- Steve Rogerson
Bloom IVF Group, one of the oldest IVF chains in India, is using artificial intelligence (AI) technology across its clinics to help patients get pregnant sooner and more affordably.
The AI software, called Life Whisperer from California-based Presagen, analyses images of patient embryos to assess their quality, supporting the embryologist in identifying the embryo most likely to lead to a successful outcome.
Life Whisperer uses AI to assess two embryo quality metrics. First, it assesses how likely an embryo is to lead to a pregnancy and, secondly, it non-invasively assesses embryo ploidy. Life Whisperer is authorised for sale in more than 40 countries worldwide, including India.
The use of Life Whisperer is backed by scientific evidence, clinical data and numerous recent publications.
“After extensively testing Life Whisperer’s performance in our own labs, we are excited to be able to offer this new affordable technology for our patients to ensure they can receive the most advanced IVF treatment possible,” said Bloom IVF Group’s medical director Hrishikesh Pai.
Nandita Palshetkar, founder of Bloom IVF Group, added: “This is in line with our mission of being one of the leaders in fertility treatment in India, an achievement we have held for 30 years.”
And Presagen’s CEO Michelle Perugini said: “We look forward to working with Bloom IVF Group network, who have a reputation for using the latest technology and applying scientific rigour to provide world-leading fertility treatment for their patients.”
Each patient that uses Life Whisperer may also receive an AI report of their embryos, not only as a keepsake but also to provide additional transparency and confidence around their IVF procedure.
Bloom IVF Group and Presagen have a long-term partnership to continue furthering the advancement of AI in fertility, collaborating to build additional AI technology with the aim of improving IVF outcomes for patients in India and globally.